Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma-Reference-Cited by-同舟云学术

Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma

Published:2016-09-07 Issue:1 Volume:8 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Kristensen Lasse Sommer,Hansen Jakob Werner,Kristensen Søren Sommer,Tholstrup Dorte,Harsløf Laurine Bente Schram,Pedersen Ole Birger,De Nully Brown Peter,Grønbæk Kirsten

Funder

Kræftens Bekæmpelse

Novo Nordisk

Van Andel Research Institute

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-016-0261-y.pdf

Reference39 articles.

1. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265–76.

2. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med. 2002;346(4):235–42.

3. Larouche JF, Berger F, Chassagne-Clement C, Ffrench M, Callet-Bauchu E, Sebban C, Ghesquieres H, Broussais-Guillaumot F, Salles G, Coiffier B. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J Clin Oncol. 2010;28(12):2094–100.

4. El-Galaly TC, Jakobsen LH, Hutchings M, de Nully BP, Nilsson-Ehle H, Szekely E, Mylam KJ, Hjalmar V, Johnsen HE, Bogsted M, et al. Routine imaging for diffuse large B-cell lymphoma in first complete emission does not improve post-treatment survival: a Danish-Swedish population-based study. J Clin Oncol. 2015;33(34):3993–8.

5. Dawson SJ, Seymour JF. Large B-cell lymphoma: is the future written in the blood? Lancet Oncol. 2015;16(5):481–3.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies;Trends in Molecular Medicine;2024-07

2. Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?;Current Treatment Options in Oncology;2024-04-24

3. 5-hydroxymethylcytosine Profilings in Circulating Cell-free DNA as diagnostic biomarkers for DLBCL;2023-12-11

4. Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment;CLIN CANCER RES;2023

5. Thymic lymphoma detection in RORγ knockout mice using 5-hydroxymethylcytosine profiling of circulating cell-free DNA;Toxicology and Applied Pharmacology;2023-08